Plain-English translation of NCT06684314 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Hemophilia A research guide →This study is tracking how well works as a preventive treatment for hemophilia A, and how it affects joint health over time. Researchers will collect information about the medication's effectiveness and safety by reviewing your medical records and monitoring you during regular clinic visits for up to five years. The goal is to understand whether this preventive approach helps protect your joints from damage.
Hemophilia A can cause serious joint damage over time if bleeding isn't prevented. This study wants to learn whether using this medication as a preventive treatment can keep joints healthier and prevent long-term complications.
You likely qualify if…
You likely don't qualify if…
You would continue your regular hemophilia clinic visits over five years—no extra study visits are required. Researchers will collect information about your treatment from your medical records (looking back at least 12 months before you started the medication, and forward for up to five years after). They will also arrange joint imaging scans (ultrasound or MRI) at centers that offer them to monitor your joint health. Your doctor will decide to start you on this preventive medication as part of your normal care, independent of the study.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Taiwan